
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Single-use filtration technology is becoming increasingly popular as manufacturers seek to cut costs and minimize processing times.
about 23 years ago
September 2003about 23 years ago
In the Spotlight September 2003about 23 years ago
Counterfeiting, Compliance, and Controlsabout 23 years ago
September 2003about 23 years ago
CROs Hoping for Research Burst in Second Half of 2003





